abiraterone,docetaxel
cspc pharmaceuticals,novo nordisk
['cspc', 'gu ', 'peace-1', 'novo ', 'cspc ']
#asco23 peace-1 trial by dr. bossi significant delay in disease progression and delay of serious gu obstructive events by radiation therapy in mcspc (no os benefit): results confirm the role of radiation in low volume denovo mcspc 
Medical Oncologist. Editor-in-chief: @ASCO Daily News; Presidential Endowed Chair, @HuntsmanCancer (NCI-CCC) @UUtah, FCOI https://t.co/ywWAdZmBWt